Mustang Bio, Inc.
Veridion Score
Composite trend over time
Why is MBIO moving today?
Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs into potential cures for difficult-to-treat cancers. It acquires rights to these technologies by licensing or otherwise acquiring an ownership interest in the technologies, funding their research and development, and eventually either out-licensing or bringing the technologies to market. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Warehouse intelligence for MBIO.
MBIO insider activity
Mustang Bio, Inc.
No multi-insider buying cluster in the last 90 days
Mixed: Not disclosed across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
The current Form 4 feed did not return value-bearing open-market rows for MBIO.
MBIO contract awards, year to date.
Public federal awards linked to this ticker.
MBIO lobbying filings, year to date.
Registered lobbying filings matched to Mustang Bio, Inc..